Skip to content

Comparative study of the outcome regarding the infection rate of ABO incompatible kidney transplant patients treated with Antigen Specific Immunoadsorption (IA) or Non-Antigen Specific IA

Comparative study of the outcome regarding the infection rate of ABO incompatible kidney transplant patients treated with Antigen Specific Immunoadsorption (IA) or Non-Antigen Specific IA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022385
Enrollment
140
Registered
2020-07-28
Start date
2021-07-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney failure, ABOi kidney transplantation N18.5

Interventions

Group 1: bloodgroup - Ab speciffic IA Group 2: Ab unspecific IA

Sponsors

Klinik für Viszeral- und Allgemeinchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ABOi living donation recipients

Exclusion criteria

Exclusion criteria: other transplantations, <18 years of age

Design outcomes

Primary

MeasureTime frame
rate of infection

Secondary

MeasureTime frame
titer course, number of immunoadsorptions, graft and patient survival, complications

Countries

Germany

Contacts

Public ContactBernd Jänigen

Klinik für Viszeral- und Allgemeinchirurgie

bernd.jaenigen@uniklinik-freiburg.de0761/270-27320

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026